Gene therapy: Began Phase I/II trial

Genetic Therapy Inc. (GTII), Gaithersburg, Md. Product: Gene therapy using a new, genetically altered vector to transfer the HS-tk gene for thymidine kinase into cancer cells, which renders them susce...